PPPharmacy
ActiveSummary
PPPharmacy has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €84,763 and a net result of €49,925. Equity is growing by about 26% per year across the filed financial years. Its solvency ranks better than 87% of 22,153 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
24-01
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
30-06
Financial
Weakest financial yearnet €49,925 ▼35.1%
Net result drops to €49,925, the lowest in the series.
24-01
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
30-06
Financial
Equity above €200,000equity €224,114 ▲52.2%
A profit in every financial year since 2022 builds equity to €224,114.
29-01
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
30-06
Financial
Liquidity more than doubledcurrent ratio 8.36
Current ratio from 3.99 to 8.36; short-term debt falls from €25,722 to €18,928.
30-06
Financial
Equity above €100,000equity €147,216 ▲70.7%
A profit in every financial year since 2022 builds equity to €147,216.
31-01
NBB filing
Annual accounts filed
financial year 2022 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.